Thailand Launches Roadmap to Become a Clinical Research Hub

According to a report by Thai Post on September 7, 2026, the Health Systems Research Institute (HSRI) and the Pharmaceutical Research and Manufacturers Association (PReMA) have officially joined forces for the first time. This collaboration is focused on developing a comprehensive roadmap designed to elevate Thailand’s status as a regional hub for clinical research.

For residents and expatriates, this initiative is significant as it aims to accelerate the availability of medical innovations and advanced treatments within the country. By fostering a more robust clinical research environment, the partnership seeks to improve patient access to cutting-edge therapies that may not have been readily available previously.

While the announcement outlines a clear intent to modernize the national healthcare research infrastructure, several details remain to be confirmed. Specifically, the public has yet to see the finalized timeline for the implementation of these research protocols or the specific types of medical innovations that will be prioritized under this new framework. As the roadmap progresses, further updates are expected regarding how these changes will integrate with existing public health services and private medical facilities across Thailand.